Militia Capital Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Sell
23,356
-22,307
-49% -$1.14M 0.03% 202
2026
Q2
$2.41M Hold
45,663
– – 0.07% 108
2026
Q1
$1.9M Buy
+45,663
New +$1.87M 0.19% 108

Other funds holding BBC

Militia Capital Management's BBC Position: Q3 2026 in Review

Militia Capital Management reduced its Virtus Biotech Clinical Trials ETF (BBC) stake by 49% in Q3 2026, selling an estimated $1.14M and leaving 23,356 shares worth $1.08M. The position accounts for 0.03% of the portfolio, ranked #202.

Militia Capital Management first reported a position in BBC in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.41M in Q2 2026. 17 funds tracked by Wall St. Rank hold BBC as of Q3 2026.

  • Militia Capital Management held 23,356 shares of Virtus Biotech Clinical Trials ETF worth $1.08M as of Q3 2026.
  • Militia Capital Management sold 22,307 Virtus Biotech Clinical Trials ETF shares in Q3 2026, an estimated $1.14M.
  • Virtus Biotech Clinical Trials ETF made up 0.03% of Militia Capital Management's portfolio in Q3 2026, its #202 holding.
  • Militia Capital Management first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2026 and has held it in 3 quarters since.
  • Militia Capital Management's Virtus Biotech Clinical Trials ETF position peaked at $2.41M in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.

Based on Militia Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.